title: Efficiency of an mTOR Inhibitor in Kasabach-Merritt Phenomenon with Indolent Tufted Angioma: A Case Report.
authors.affiliation: Department of Dermatology, Centre Hospitalier Universitaire, FR-25000 Besancon, France.
authors.forename: Charlée
authors.initials: C
authors.lastname: Nardin
authors.forename: Olivia
authors.initials: O
authors.lastname: Boccara
authors.forename: Catherine
authors.initials: C
authors.lastname: Eschard
authors.forename: Michael
authors.initials: M
authors.lastname: Bayaram
authors.forename: Thibaud
authors.initials: T
authors.lastname: Dabudyk
authors.forename: François
authors.initials: F
authors.lastname: Aubin
authors.forename: Eve
authors.initials: E
authors.lastname: Puzenat
mesh_terms: D006391:Hemangioma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D007223:Infant; D059885:Kasabach-Merritt Syndrome / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000201:enzymology; D008279:Magnetic Resonance Imaging; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000201:enzymology; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D047428:Protein Kinase Inhibitors; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus